LY3090106

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3090106, covering 2015-10-01 to 2015-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) [Phase 1]